What is Opus Genetics's common stock, shares, outstanding?

Opus Genetics (IRD) reported common stock, shares, outstanding of $71.4M in Q1 2026.

How has Opus Genetics's common stock, shares, outstanding changed year-over-year?

Opus Genetics's common stock, shares, outstanding increased by 57.0% year-over-year, from $45.48M to $71.4M.

What is the long-term trend for Opus Genetics's common stock, shares, outstanding?

Over 5 years (2020 to 2025), Opus Genetics's common stock, shares, outstanding has grown at a 45.1% compound annual growth rate (CAGR), from $10.88M to $69.89M.

Opus Genetics IRD Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Prime MedicinePRME

——

PrecigenPGEN

——

BridgeBio PharmaBBIO

——

HRO

HarrowHROW

——

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's common stock, shares, outstanding?: Opus Genetics (IRD) reported common stock, shares, outstanding of $71.4M in Q1 2026.
How has Opus Genetics's common stock, shares, outstanding changed year-over-year?: Opus Genetics's common stock, shares, outstanding increased by 57.0% year-over-year, from $45.48M to $71.4M.
What is the long-term trend for Opus Genetics's common stock, shares, outstanding?: Over 5 years (2020 to 2025), Opus Genetics's common stock, shares, outstanding has grown at a 45.1% compound annual growth rate (CAGR), from $10.88M to $69.89M.